Axsome Therapeutics, Inc (AXSM) Dividend History

Company News

• Axsome Therapeutics to Participate in Upcoming Investor Conferences

  Axsome Therapeutics announced participation in multiple healthcare investor conferences in September 2025, including Wells Fargo, Cantor, Morgan Stanley, and others, presenting fireside chats and investor meetings.

  GlobeNewswire Inc.
• 2 Soaring Stocks Wth More Upside Potential

  The article discusses two biotech companies, Summit Therapeutics and Axsome Therapeutics, that have seen significant stock price gains in recent years. Despite their recent performance, the author believes there is still potential upside for investors in these companies.

  The Motley Fool

  Featured Companies: SMMT
• Why Is Teva Stock Trading Higher On Tuesday?

  Teva Pharmaceutical and Biolojic Design announced that Teva initiated IND-enabling studies with BD9, a dual-specific multibody targeting both TSLP and IL-13, which can potentially improve outcomes for patients with conditions such as atopic dermatitis and asthma.

  Benzinga

  Featured Companies: ALVO JNJ
• Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe

  Intra-Cellular (ITCI) is witnessing strong Caplyta sales, driven by an increasing prescription rate. However, the company is heavily dependent on Caplyta sales for growth, which is a concern.

  Zacks Investment Research

  Featured Companies: ALXO ANVS
• Buy These Stocks; Members Of The Most Hated Tech Sector

  Biotech stocks have been heavily impacted by rising interest rates and FTC challenges. Find out my investment strategy while selecting biotech names.

  Seeking Alpha

  Featured Companies: AKRO APLS IBB SAGE XBI